After 12 cycles of cetuximab/FOLFIRI (5-fluorouracil, leucovorin, irinotecan) chemotherapy, the patient underwent palliative surgical resection of colon cancer which revealed poorly differentiated adenocarcinoma, demonstrated diffuse and intense ALK staining (3+) by ALK IHC (Figure 3B). Here, ALK is linked to adenocarcinoma.